Thyrocare Technologies share price

Balanced risk
  • 44%Low risk
  • 44%Moderate risk
  • 44%Balanced risk
  • 44%High risk
  • 44%Extreme risk
  • 1,023.40(3.96%)
    June 13, 2025 15:29:01 PM IST
    • NSE
    • BSE
  • Vol : 110.00K (NSE + BSE)
    Last 20 day avg : 88.28 K

Thyrocare Technologies is trading 3.96% upper at Rs 1,023.40 as compared to its last closing price. Thyrocare Technologies has been trading in the price range of 1,028.90 & 971.05. Thyrocare Technologies has given 8.04% in this year & -1.16% in the last 5 days. Thyrocare Technologies has TTM P/E ratio 39.38 as compared to the sector P/E of 23.24.There are 1 analysts who have initiated coverage on Thyrocare Technologies. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 21.70 Crores in its last quarter.Listed peers of Thyrocare Technologies include Healthcare Global Enterprises (0.89%), Kovai Medical Cente And Hospital (-0.69%), Thyrocare Technologies (3.96%).The Mutual Fund holding in Thyrocare Technologies was at 12.97% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Thyrocare Technologies was at 2.41% in 31 Mar 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Jun 13, 2025, 01:27 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    2.13
    Higher than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    9.55
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    57.24
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.80
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.05
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
971.05
Highest
1,028.90
52 week range
Lowest
605.05
Highest
1,072.45
Thyrocare Technologies Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in March quarter by 21.34% from Rs 187.16 crore to Rs 154.25 crore, year-on-year
    • financial-insightsThe company has grown its March quarter profit by 22.05% from Rs 17.78 crore to Rs 21.70 crore, year-on-year
    • financial-insightsThe debt to equity of the company is lower than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Thyrocare Technologies Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 1,122.78
  • R2
  • 1,195.22
  • R3
  • 1,317.98
Pivot1,000.02
  • S1
  • 927.58
  • S2
  • 804.82
  • S3
  • 732.38
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Thyrocare Technologies Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Healthcare Global Enterprises
Bullish
549.600.897,676.26173.798.25-149.57
Kovai Medical Cente And Hospital
Neutral
5,937.00-0.696,495.3931.666.090.1734.88
Thyrocare Technologies
Bullish
1,023.403.965,403.8858.279.651.813.09
Indraprastha Medical Corp
Bearish
409.25-0.463,755.7524.056.491.075.12
Artemis Medicare Services
Bearish
260.400.043,625.8849.954.360.1729.74
Thyrocare Technologies Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Thyrocare Technologies is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPledged found - Promoter(s) have pledged 100.00% of shares.
    • InsightsPledging Flat - Promoter(s) pledging has not increased in last quarter.
    • InsightsPromoter(s) holds a high stake in the company at 71.06%
    • InsightsPromoter(s) have decreased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has decreased by 0.36 percentage points from previous quarter
    • InsightsMutual Funds holding has increased by 0.22 percentage points from previous quarter
    Thyrocare Technologies Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-04-23Audited Results & Final Dividend
    2025-01-23Quarterly Results
    2024-10-23Quarterly Results
    2024-07-23Quarterly Results
    2024-05-14Audited Results & Final Dividend
    About the company Thyrocare Technologies
    • IndustryHealthcare Facilities
    • ISININE594H01019
    • BSE Code539871
    • NSE CodeTHYROCARE
    Thyrocare Technologies Limited is an India-based company, which operates as a healthcare services provider. It conducts an array of medical diagnostic tests and profiles of tests that are focused on early detection and management of health disorders and diseases. Its segments include diagnostic testing services, imaging services, and others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services includes diagnostic and imaging services, selling of radiopharmaceuticals, selling of consumables for reporting. The Others segment includes the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. It has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India. It is also focused on offering pathological services.
    • Management Info
    • Rahul GuhaExecutive Chairman of the Board, Chief Executive Officer, Managing Director
    • Alok JagnaniChief Financial Officer
    • Brijesh KumarCompliance Officer, Company Secretary
    Thyrocare Technologies Share Price FAQs

    Thyrocare Technologies is trading at 1023.40 as on Fri Jun 13 2025 09:59:01. This is 3.96% upper as compared to its previous closing price of 984.40.

    The market capitalization of Thyrocare Technologies is 5403.88 Cr as on Fri Jun 13 2025 09:59:01.

    The average broker rating on Thyrocare Technologies is Strong Buy. The breakup of analyst rating is given below -

    • 1 analysts have given a strong buy rating
    • 0.00 analysts have given a buy rating
    • 0.00 analysts have given a hold rating
    • 0.00 analysts have given a sell rating
    • 0.00 analysts have given a strong sell rating

    The 52 wk high for Thyrocare Technologies is 1072.45 whereas the 52 wk low is 605.05

    Thyrocare Technologies can be analyzed on the following key metrics -

    • TTM P/E: 39.38
    • Sector P/E: 23.24
    • Dividend Yield: 2.13%
    • D/E ratio: 0.05

    Thyrocare Technologies reported a net profit of 91.51 Cr in 2025.

    The Mutual Fund Shareholding was 12.97% at the end of 31 Mar 2025.